Published in Prion on October 10, 2012
Prions and the potential transmissibility of protein misfolding diseases. Annu Rev Microbiol (2013) 1.04
Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer's disease. Sci Rep (2015) 0.76
Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism. J Exp Med (2017) 0.75
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet (1998) 7.70
Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol (1994) 5.20
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science (2010) 3.98
2011 Alzheimer's disease facts and figures. Alzheimers Dement (2011) 3.91
The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron (2009) 3.68
Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med (2010) 3.67
Adverse cerebral effects of anaesthesia on old people. Lancet (1955) 3.53
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol (2011) 2.94
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci (2000) 2.41
Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A (2009) 2.27
Abeta species removal after abeta42 immunization. J Neuropathol Exp Neurol (2006) 2.25
Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc (1994) 2.21
Alzheimer's disease: a study of epidemiological aspects. Ann Neurol (1984) 2.17
Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans. Brain Pathol (2011) 2.11
A case-control study of Alzheimer's disease in Australia. Neurology (1990) 1.98
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci (2006) 1.77
Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J Neurosci (2011) 1.66
Postoperative delirium in the elderly. Br J Anaesth (1994) 1.63
Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology (1986) 1.48
Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. Int J Neurosci (1994) 1.48
Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease. Neuroepidemiology (2012) 1.47
Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br J Psychiatry (2001) 1.46
A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci (2002) 1.38
Evidence for and against the transmissibility of Alzheimer disease. Neurology (1980) 1.34
De novo induction of amyloid-β deposition in vivo. Mol Psychiatry (2011) 1.32
Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol (1994) 1.31
"Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?". Can J Neurol Sci (1982) 1.19
Transmission of scrapie in hamsters. J Infect Dis (1985) 1.16
Prion-like aggregates: infectious agents in human disease. Trends Mol Med (2010) 1.13
Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice. PLoS One (2011) 1.12
Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses. Mol Neurobiol (1994) 1.06
Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 1.04
Herpes simplex virus and Alzheimer's disease: a search for virus DNA by spot hybridisation. J Neurol Neurosurg Psychiatry (1984) 1.01
Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease. Anaesthesia (2010) 1.01
Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. J Alzheimers Dis (2010) 1.00
Amyloid: little proteins, big clues. Nature (2011) 1.00
Alzheimer's disease and anesthesia. Front Neurosci (2011) 1.00
Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. J Neuropathol Exp Neurol (2011) 0.99
The Nun Study: risk factors for pathology and clinical-pathologic correlations. Curr Alzheimer Res (2012) 0.98
[Genetic and environmental factors that may influence in the senile form of Alzheimer's disease: nested case control studies]. Neurologia (2009) 0.96
Spine Surgery under general anesthesia may not increase the risk of Alzheimer's disease. Dement Geriatr Cogn Disord (2010) 0.96
Transmission studies from blood of Alzheimer disease patients and healthy relatives. Proc Natl Acad Sci U S A (1988) 0.95
Infectivity of amyloid diseases. Trends Mol Med (2002) 0.93
Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am J Pathol (1993) 0.92
A case-control study of Alzheimer's disease. Ann Neurol (1990) 0.91
Neurocognitive impairment and driving performance after coronary artery bypass surgery. Eur J Cardiothorac Surg (2003) 0.89
Alzheimer's disease: environmental factors and etiologic hypotheses. Can J Neurol Sci (1989) 0.88
Alzheimer's disease and history of blood transfusion by apolipoprotein-E genotype. Neuroepidemiology (1997) 0.87
Herpes-simplex viral genome and senile and presenile dementias of Alzheimer and Pick. Lancet (1980) 0.87
Medicine. Prion-like behavior of amyloid-beta. Science (2010) 0.85
Cognitive dysfunction after surgery and anaesthesia: what can we tell the grandparents? Age Ageing (2009) 0.84
Senile dementia of the Alzheimer type: possibility of infectious etiology in genetically susceptible individuals. Acta Neurol Scand Suppl (1984) 0.83
Prion distribution in hamster lung and brain following intraperitoneal inoculation. J Gen Virol (1998) 0.81
Human herpes virus infections and Alzheimer's disease. Neuropathol Appl Neurobiol (1990) 0.81
Prior blood transfusions and Alzheimer's disease. Neurology (1994) 0.78
Perspectives on the etiology of Alzheimer's disease. JAMA (1987) 0.77
A new story about an old guy: is Alzheimer's disease infectious? Neurodegener Dis (2010) 0.77
Transient appearance of amyloid precursor protein plaques in the brain of thymectomized rats after human leptomeningeal cell grafts. Neurosci Lett (2002) 0.77
Cause-specific mortality among neurosurgeons. J Neurosurg (2010) 0.76
Detection of herpes virus genome in Alzheimer's disease by in situ hybridization: a preliminary study. J Neural Transm Suppl (1987) 0.76
Transmissible cerebral amyloidoses as a model for Alzheimer's disease. An ultrastructural perspective. Mol Neurobiol (1994) 0.76
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci (2009) 1.89
Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol (2004) 1.74
Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol (2005) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Genes contributing to prion pathogenesis. J Gen Virol (2008) 1.51
Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls. World J Biol Psychiatry (2010) 1.45
Quinpramine is a novel compound effective in ameliorating brain autoimmune disease. Exp Neurol (2008) 1.44
Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain (2006) 1.35
Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett (2004) 1.33
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol (2009) 1.32
Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J Neurosci (2008) 1.32
Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One (2013) 1.30
Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke (2006) 1.29
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain (2012) 1.24
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol (2009) 1.21
C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-β. Brain (2012) 1.20
Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol Neurobiol (2014) 1.19
Rapidly progressive Alzheimer disease. Arch Neurol (2011) 1.19
MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain (2005) 1.18
Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci U S A (2010) 1.18
alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation. J Neurochem (2009) 1.15
Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2006) 1.15
Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J Alzheimers Dis (2008) 1.14
Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J Neurochem (2006) 1.13
Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. Hum Mol Genet (2011) 1.12
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol (2007) 1.12
Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes. Biol Psychiatry (2011) 1.11
Ebola risk perception in Germany, 2014. Emerg Infect Dis (2015) 1.10
Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuropathol (2005) 1.09
Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C. Biochemistry (2009) 1.07
Human prion strain selection in transgenic mice. Ann Neurol (2010) 1.06
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. J Psychiatr Res (2010) 1.06
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD? BMC Neurol (2006) 1.06
Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure. J Neurochem (2010) 1.02
Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann Neurol (2003) 1.02
Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol (2006) 1.02
Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation. Neurogenetics (2008) 1.02
Fatal familial insomnia: Clinical features and early identification. Ann Neurol (2008) 1.01
Clinical features of rapidly progressive Alzheimer's disease. Dement Geriatr Cogn Disord (2010) 1.00
Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry (2013) 1.00
Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic mice. ACS Chem Neurosci (2010) 0.98
Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis (2009) 0.98
A chimeric ligand approach leading to potent antiprion active acridine derivatives: design, synthesis, and biological investigations. J Med Chem (2006) 0.96
Urinary alpha1-antichymotrypsin: a biomarker of prion infection. PLoS One (2008) 0.96
Impact of vCJD on blood supply. Biologicals (2007) 0.95
Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk. Neurobiol Aging (2011) 0.95
Brain biopsy in patients with suspected Creutzfeldt-Jakob disease. J Neurosurg (2008) 0.95
High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease. Brain (2014) 0.94
Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis. J Neurol (2013) 0.93
Endothelial LRP1 transports amyloid-β1-42 across the blood-brain barrier. J Clin Invest (2015) 0.93
Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol (2009) 0.93
Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol (2005) 0.92
TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABP. Neurobiol Dis (2010) 0.92
Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol (2002) 0.92
Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis (2014) 0.91
Rapidly progressive Alzheimer's disease: a multicenter update. J Alzheimers Dis (2012) 0.91
Latrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol (2003) 0.90
Therapeutic approaches for prion disorders. Expert Rev Anti Infect Ther (2007) 0.90
Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol (2005) 0.89
Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Mov Disord (2009) 0.89
Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum Mol Genet (2012) 0.89
Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol (2005) 0.89
Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs. J Cell Biol (2014) 0.88
Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia. Restor Neurol Neurosci (2008) 0.88
The expanded octarepeat domain selectively binds prions and disrupts homomeric prion protein interactions. J Biol Chem (2005) 0.87
Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells. J Proteome Res (2011) 0.86
Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier. J Cereb Blood Flow Metab (2012) 0.86
Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain (2010) 0.86
Vaccine approaches to prevent and treat prion infection : progress and challenges. BioDrugs (2008) 0.86
Immunotherapy in prion disease. Nat Rev Neurol (2012) 0.86
Identification of I137M and other mutations that modulate incubation periods for two human prion strains. J Virol (2012) 0.86
Magnetic resonance imaging in E200K and V210I mutations of the prion protein gene. Alzheimer Dis Assoc Disord (2013) 0.85
Genetic prion disease with codon 196 PRNP mutation: clinical and pathological findings. Neurobiol Aging (2011) 0.85
Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effects. J Med Chem (2006) 0.85
Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis (2007) 0.85
Diagnostic problems during late course in Creutzfeldt-Jakob disease. J Neurol (2003) 0.85
Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity. Mol Immunol (2008) 0.84
Physiological role of the cellular prion protein (PrPc): protein profiling study in two cell culture systems. J Proteome Res (2008) 0.84
Combining independent drug classes into superior, synergistically acting hybrid molecules. Angew Chem Int Ed Engl (2010) 0.84
Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions. J Virol (2011) 0.84
Psychiatric symptoms in patients with sporadic Creutzfeldt-Jakob disease in Germany. J Clin Psychiatry (2015) 0.83
Human and rat brain lipofuscin proteome. Proteomics (2012) 0.83
Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein. Biochemistry (2008) 0.83
Pulvinar sign in Wernicke's encephalopathy. CNS Spectr (2010) 0.83
Novel PRNP mutation in a patient with a slow progressive dementia syndrome. Med Sci Monit (2008) 0.83
A novel subtype of Creutzfeldt-Jakob disease characterized by a small 6 kDa PrP fragment. Acta Neuropathol (2007) 0.83
Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease. J Alzheimers Dis (2014) 0.82
The use of conformation-specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases. J Neurosci Res (2007) 0.82
Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene. Neurogenetics (2005) 0.82
Alzheimer's disease: genetic polymorphisms and rate of decline. Dement Geriatr Cogn Disord (2012) 0.82
Randomized, placebo-controlled trial or post hoc subgroup analysis: the importance of standardized and comprehensive reporting. J Infect Dis (2014) 0.82
Dura mater graft-associated Creutzfeldt-Jakob disease: the first case in Korea. J Korean Med Sci (2011) 0.81
Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease. J Alzheimers Dis (2011) 0.81
Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain (2002) 0.81
Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS One (2008) 0.81